首页> 外文期刊>Oncogenesis. >Estrogen receptor-α regulation of microRNA-590 targets FAM171A1—a modifier of breast cancer invasiveness
【24h】

Estrogen receptor-α regulation of microRNA-590 targets FAM171A1—a modifier of breast cancer invasiveness

机译:microRNA-590的雌激素受体-α调控靶向FAM171A1——乳腺癌侵袭性的调节剂

获取原文
           

摘要

The pathobiology and aggressiveness of the triple negative breast cancer (TNBC) are influenced by genes that are preferentially expressed in TNBC cells. However, the nature of such genes with the role in invasiveness of TNBC cells is not fully understood. Here, we identified FAM171A1, member (A1) of the family with sequence similarity 171, as an overexpressed candidate gene in TNBC cells and tumors as compared to estrogen receptor-alpha (ERα) positive breast cancer. We found that the expression of FAM171A1 correlates well with the loss of ERα as well as its newly identified target miR590-5p in TNBC but not in ERα-positive cells. In addition, we report that ERα regulates FAM171A1 expression through a mechanism which involves ERα stimulation of miR590-5p expression via binding to its promoter, and in-turn, miR590-5p suppression of FAM171A1 expression. Further, we found that the levels of FAM171A1 correlate well with cancer cell aggressiveness as depletion or overexpression of FAM171A1 confers reduced or increased ability of TNBC cells to form mammospheres, respectively in accordance with the previous report of increased mammosphere formation potential of metastatic cells. In brief, results presented here have demonstrated that ERα regulation of FAM171A1 expression via miR590-5p explains the molecular basis of the noticed reduced levels of FAM171A1 in ER-positive breast cancer cells and that FAM171A1 is a preferably TNBC- overexpressed gene. Further, the noted loss of ERα-miR590-5p axis may upregulate the expression of FAM171A1 and consequently, resulting aggressiveness of TNBC cells. These findings suggest that FAM171A1 might represent a potentially novel therapeutic target for TNBC tumors.
机译:三阴性乳腺癌(TNBC)的病理生物学和侵袭性受到TNBC细胞中优先表达的基因的影响。但是,尚未完全了解这种基因在TNBC细胞侵袭中的作用。在这里,我们鉴定出具有序列相似性171的家族成员(A1)FAM171A1是TNBC细胞和肿瘤中与雌激素受体α(ERα)阳性乳腺癌相比过表达的候选基因。我们发现,FAM171A1的表达与ERα的丢失以及其新发现的目标miR590-5p在TNBC中的表达相关,而与在ERα阳性细胞中的表达无关。此外,我们报告说,ERα通过一种机制调节FAM171A1表达,该机制涉及ERα通过与其启动子结合刺激miR590-5p表达,进而抑制miR590-5p抑制FAM171A1表达。此外,我们发现FAM171A1的水平与癌细胞的侵袭性密切相关,因为FAM171A1的耗竭或过表达分别赋予TNBC细胞形成乳球的能力降低或增加的能力,这与先前报道的转移细胞形成乳腺球的潜力增加有关。简而言之,此处给出的结果表明,通过miR590-5p对ERα调节FAM171A1的表达解释了ER阳性乳腺癌细胞中FAM171A1降低的水平的分子基础,并且FAM171A1是优选TNBC过表达的基因。此外,注意到的ERα-miR590-5p轴缺失可能会上调FAM171A1的表达,从而导致TNBC细胞的侵袭性。这些发现表明,FAM171A1可能代表TNBC肿瘤的潜在新型治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号